Nanobiotix SA
22.94
EUR
+2.58
(+12.67%)
Important Dates
Nanobiotix SA's next confirmed earnings release is scheduled for April 27, 2027.
| Earnings Date | 4/27/2027 |
Share Statistics
As of December 31, 2025, Nanobiotix SA has 48.39M shares outstanding.
| Shares Outstanding | 48.39M |
Financial Position
As of December 31, 2025, Nanobiotix SA maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.09 |
| Quick Ratio | 1.05 |
| Debt / Equity | -112.83 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 102.50 |
Balance Sheet
EURAs of December 31, 2025, Nanobiotix SA holds 52.75M in cash and equivalents against 95.32M in total debt, resulting in a net debt position of 39.47M. Total book value stands at -84.48M, with working capital of 5.24M providing operational flexibility.
| Cash & Cash Equivalents | 52.75M |
| Total Debt | 95.32M |
| Net Debt | 39.47M |
| Equity (Book Value) | -84.48M |
| Book Value Per Share | -1.75 |
| Working Capital | 5.24M |
Stock Splits
Nanobiotix SA's most recent stock split took place on February 25, 2014.
| Last Split Date | 2/25/2014 |